(Q33794890)

29 July 2017

Determinants of survival in patients with brain metastases from cutaneous melanoma (English)

1 reference

29 July 2017

U Leiter

3

0 references

Thomas Kurt Eigentler

object named as

T Eigentler

5

0 references

author name string

M Staudt

1

1 reference

29 July 2017

K Lasithiotakis

2

1 reference

29 July 2017

F Meier

4

1 reference

29 July 2017

M Bamberg

6

1 reference

29 July 2017

M Tatagiba

7

1 reference

29 July 2017

P Brossart

8

1 reference

29 July 2017

C Garbe

9

1 reference

29 July 2017

language of work or name

English

0 references

publication date

6 April 2010

1 reference

British Journal of Cancer

29 July 2017

1 reference

29 July 2017

102

1 reference

29 July 2017

8

1 reference

29 July 2017

1213-1218

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6605622

29 July 2017

0 references

cites work

Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

A prognostic index that predicts outcome following palliative whole brain radiotherapy for patients with metastatic malignant melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Determinants of outcome in melanoma patients with cerebral metastases

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Treatment of brain metastases from melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Selection of patients with melanoma brain metastases for aggressive treatment

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

The treatment of brain metastases from malignant melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Survival by radiation therapy oncology group recursive partitioning analysis class and treatment modality in patients with brain metastases from malignant melanoma: a retrospective study

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Prognostic factors in metastatic melanoma: a pooled analysis of Eastern Cooperative Oncology Group trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Surgical treatment of brain metastases from melanoma: a retrospective study of 91 patients

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Brain metastases. Histology, multiplicity, surgery, and survival

28 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

LDH correlation with survival in advanced melanoma from two large, randomised trials (Oblimersen GM301 and EORTC 18951).

28 July 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Prognostic factors for survival after stereotactic radiosurgery vary with the number of cerebral metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Multidisciplinary management of brain metastases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Brain metastases treated with radiosurgery alone: an alternative to whole brain radiotherapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Temozolomide in combination with interferon-alfa versus temozolomide alone in patients with advanced metastatic melanoma: a randomized, phase III, multicenter study from the Dermatologic Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Multimodality treatment of melanoma brain metastases incorporating stereotactic radiosurgery (SRS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Prolonged survival of 2 years or longer for patients with disseminated melanoma. An analysis of related prognostic factors.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Patterned distribution of metastases from malignant melanoma in humans.

30 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2856002

Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma

30 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605622

Time trends of cutaneous melanoma in Queensland, Australia and Central Europe

21 January 2018

1 reference

12 December 2020

Intracerebral metastases in solid-tumor patients: Natural history and results of treatment

1 reference

12 December 2020

Prognostic factors in patients with metastatic malignant melanoma. A multivariate analysis

1 reference

12 December 2020

[Position and recommendations of the Malignant Melanoma Committee of the German Society of Dermatology on diagnosis, treatment and after-care of malignant melanoma of the skin. Status 1993/94]

1 reference

12 December 2020

[Brief guidelines: malignant melanoma of the skin]

1 reference

12 December 2020

Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6605622

1 reference

Dimensions Publication ID

29 July 2017

0 references

1 reference

29 July 2017

1 reference